Información:
Error:
ID
34140
Descripción
Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT02334254
Link
https://clinicaltrials.gov/show/NCT02334254
Palabras clave
Versiones (1)
- 14/1/19 14/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
14 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Atrial Fibrillation NCT02334254
Eligibility Atrial Fibrillation NCT02334254
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT02334254
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
a long-term indication for oral anticoagulation treatment (until at least 1 year after the study)
boolean
ID.2
Item
a severe coronary lesion (at least 75% stenosis on angiography or fractional flow reserve lower than 0•80) with indication for pci
boolean
ID.3
Item
age 18-80 years
boolean
ID.4
Item
history of intracranial bleeding;
boolean
ID.5
Item
cardiogenic shock;
boolean
ID.6
Item
contra indication to use of antiplatelet or anticoagulation drugs;
boolean
ID.7
Item
peptic ulcer in the previous 6 months;
boolean
ID.8
Item
thrombo cytopenia (platelet concentration lower than 50~10⁹/l);
boolean
ID.9
Item
major bleeding (according to the thrombolysis in myocardial infarction [timi] criteria) in the past 12 months; and
boolean
ID.10
Item
pregnancy.
boolean